about
Nanoengineering approaches to the design of artificial antigen-presenting cellsCell or cell membrane-based drug delivery systemsActive targeted drug delivery for microbes using nano-carriersLiposome-Cross-Linked Hybrid Hydrogels for Glutathione-Triggered Delivery of Multiple Cargo MoleculesIn vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition mattersImmune cell impact of three differently coated lipid nanocapsules: pluronic, chitosan and polyethylene glycolAntitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.How nanotechnology can enhance docetaxel therapy.Liposome-like Nanostructures for Drug Delivery.Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cellsMerging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Mosaic Interdigitated Structure in Nanoparticle-Templated Phospholipid Bilayer Supports Partial Lipidation of Apolipoprotein A-I.Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy.Drug-loaded pseudo-block copolymer micelles with a multi-armed star polymer as the micellar exterior.Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery.The use of pH-sensitive functional selenium nanoparticles shows enhanced in vivo VEGF-siRNA silencing and fluorescence imaging.Liposome supported metal oxide nanoparticles: interaction mechanism, light controlled content release, and intracellular delivery.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.Electrophoresis of pH-regulated nanoparticles: impact of the Stern layer.Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine.Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics.Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified berberine chloride nanoparticlesMultifunctional quantum dots and liposome complexes in drug delivery.Hybrid nanomaterials of WS2 or MoS2 nanosheets with liposomes: biointerfaces and multiplexed drug delivery.Fluorescent carbon nanomaterials: "quantum dots" or nanoclusters?Synthesis of Polymer-Lipid Nanoparticles by Microfluidic Focusing for siRNA Delivery.Low affinity binding of plasma proteins to lipid-coated quantum dots as observed by in situ fluorescence correlation spectroscopy.A targeted therapy for melanoma by graphene oxide composite with microRNA carrierTunable Rigidity of (Polymeric Core)-(Lipid Shell) Nanoparticles for Regulated Cellular Uptake
P2860
Q27023634-4F0E7CBD-06B1-4D73-9C0C-41F4D335BE06Q28080710-F9AABFC7-30B7-485E-B072-093680F1833EQ28082463-29E97A7A-A9B0-4CF8-82AB-E5F48B4F9EE6Q28829477-66649C3F-0B3B-40D9-AC4A-F7DDDE084685Q34133510-7CDA7662-236C-441C-9371-F3CDE98C7AC9Q36427935-0261775E-D55B-46EB-A476-620F964C4CBFQ37074891-30E86B76-08C6-4B99-9CCE-24E27234805DQ37091683-F05E9582-F859-44B0-8720-A39A7281DA53Q37424654-034D1841-EEBC-40BE-818B-9E911E8E02F6Q37679875-FF430EFF-4B1E-4722-95E6-EDB5E40D33E1Q38150118-D37B6F86-29A7-42B7-813F-1390E45012B8Q38638152-9343000B-3997-439D-A5FB-B22EA7C90CA6Q38715674-510DDA33-360B-4BBE-BD26-29404E8187C7Q38856517-C92A6560-4811-4940-A068-723E543305B5Q38937032-DC2BA922-D85A-430A-BE47-ED97A528B7E3Q38978890-8AFEBE70-218E-4FDC-A1EA-CCC0748370F5Q38991520-D8B9EAAC-27B2-4856-9D44-38822AA54055Q40044791-1A123863-D89C-4C38-A40D-21D009FA6EFBQ40383799-8B5D1108-4B6A-48D0-AD47-AFF991A5B8CEQ41239757-D70198DD-938B-4886-9CF4-6967FF6C8A1DQ41547567-0EE3CAED-20D1-4F51-B4DD-F37544690935Q41953738-F446D68A-36CC-472F-9199-BB3E9960B1E6Q41968953-2FD4E652-58BC-4DC2-9982-425AD23A252BQ48672044-0D9A1FC5-A989-43F3-9D54-52B92CB1F4E3Q50275654-9432626E-085D-4D5C-92B2-7EB875B0DB9AQ50426554-418C151E-CD96-4C7D-9D8A-3591DE610EC1Q51373347-53003C43-18B2-49D7-B9D7-D4FAF030CA09Q53235543-A6AF3299-9E77-49A1-8A57-ABB61276EC77Q57071118-DF364607-7896-4DFA-B8CD-B603EB06FCC3Q57238665-29846D7A-F858-488D-8672-0C69EC25990B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lipid-enveloped hybrid nanoparticles for drug delivery.
@en
type
label
Lipid-enveloped hybrid nanoparticles for drug delivery.
@en
prefLabel
Lipid-enveloped hybrid nanoparticles for drug delivery.
@en
P2093
P2860
P356
P1433
P1476
Lipid-enveloped hybrid nanoparticles for drug delivery.
@en
P2093
P2860
P304
P356
10.1039/C2NR32880A
P407
P577
2013-01-04T00:00:00Z